Bruce A. Salzberg
Expertise in
12
conditions

Dr. Bruce A. Salzberg

Gastroenterology
Gastroenterology Consultants, P.C.
4395 Johns Creek Parkway, Ste130, 
Suwanee, GA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
12
conditions
Gastroenterology Consultants, P.C.
4395 Johns Creek Parkway, Ste130, 
Suwanee, GA 

Overview

Bruce Salzberg is a Gastroenterologist practicing medicine in Suwanee, Georgia.

Dr. Salzberg is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Ulcerative Colitis, Colitis, and Hemorrhagic Proctocolitis.

Dr. Salzberg is board certified in American Board Of Internal Medicine, 1985. He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 8 clinical trials. Dr. Salzberg is currently accepting new patients.

Specialties

Gastroenterology

Licenses

Internal Medicine in GA

Board Certifications

American Board Of Internal Medicine, 1985

Fellowships

VA Medical Ctr - Washington, DC

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Gastroenterology Consultants, P.C.
4395 Johns Creek Parkway, Ste130, Suwanee, GA 30024

Additional Areas of Focus

Dr. Salzberg has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)
Enrollment Status: Completed
Publish Date: May 13, 2026
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

10 Total Publications

Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: March 03, 2025
Similar Doctors
Expertise in
14
conditions
Dr. Parit Mekaroonkamol
Gastroenterology
Expertise in
14
conditions
Dr. Parit Mekaroonkamol
Gastroenterology
Referral may be required

Emory University School Of Medicine Department Of Ophthalmology

1365 Clifton Rd NE, 
Atlanta, GA 
 (21.0 miles away)
404-778-3184
Languages Spoken:
English

Parit Mekaroonkamol is a Gastroenterologist practicing medicine in Atlanta, Georgia. Dr. Mekaroonkamol is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pancreas Divisum, Gastroparesis, Cholecystitis, Gastrectomy, and Endoscopy.

Expertise in
28
conditions
Dr. Steven A. Keilin
Gastroenterology
Expertise in
28
conditions
Dr. Steven A. Keilin
Gastroenterology
Referral may be required
Before you request

Emory Clinic At 1365 Clifton Road

1365 Clifton Road Northeast, BldgB, 
Atlanta, GA 
 (21.0 miles away)
404-778-3184
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Steven Keilin is a Gastroenterologist practicing medicine in Atlanta, Georgia. Dr. Keilin is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Achalasia, Angiodysplasia of the Colon, Gastroparesis, Gastrectomy, and Endoscopy. Dr. Keilin is board certified in American Board Of Internal Medicine, 2007. Dr. Keilin is currently accepting new patients.

Expertise in
6
conditions
Dr. Douglas C. Wolf
Gastroenterology
Expertise in
6
conditions
Dr. Douglas C. Wolf
Gastroenterology
Referral may be required

Atlanta Gastro - United Digestive

5671 Peachtree Dunwoody Road, Ste600, 
Atlanta, GA 
 (15.0 miles away)
404-257-9000
Languages Spoken:
English, Spanish
See accepted insurances
Offers Telehealth

Douglas Wolf is a Gastroenterologist practicing medicine in Atlanta, Georgia. Dr. Wolf is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Crohn's Disease, Viral Gastroenteritis, Endoscopy, and Liver Transplant. Dr. Wolf is board certified in American Board Of Internal Medicine, 1985.

Frequently Asked Questions about Dr. Bruce A. Salzberg

How do I make an appointment with Dr. Bruce A. Salzberg?

You can book an appointment with Dr. Bruce A. Salzberg by calling their office at 678-957-0057. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Bruce A. Salzberg a top-rated expert for Crohn's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Bruce A. Salzberg is classified as an Distinguished expert for Crohn's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Bruce A. Salzberg specialize in?

While Dr. Bruce A. Salzberg is a Gastroenterology, they have specific expertise in Crohn's Disease, Ulcerative Colitis, and Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Bruce A. Salzberg participate in research or clinical trials?

Yes. Dr. Bruce A. Salzberg has published 10 articles and abstracts on conditions like Crohn's Disease. You can view a list of Dr. Bruce A. Salzberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Bruce A. Salzberg accept my insurance?

Dr. Bruce A. Salzberg accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 678-957-0057 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Salzberg's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile